Microdosing psilocybin for chronic pain: a case series
Pain September 5, 2022 Matthew Lyes, Joel Castellanos, Timothy Furnish et al. 55 citations
Abstract Psychedelic serotonergic agonists such as psilocybin have recently been shown to produce sustained benefit in refractory depression, end of life anxiety, and addiction when administered in hallucinogenic doses and coupled with psychotherapy. Although it has been suggested that similar high-dose protocols may help chronic pain conditions, there are few published clinical trials of...